These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 299880)

  • 1. Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes.
    Bonavida B
    J Exp Med; 1977 Feb; 145(2):293-301. PubMed ID: 299880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between LCM virus-specific secondary cytotoxic T lymphocytes generated by Con A and by the homologous antigen.
    Marker O; Andersen GT
    Immunology; 1979 Oct; 38(2):235-44. PubMed ID: 315920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concanavalin A-mediated in vitro activation of a secondary cytotoxic T-cell response in virus-primed splenocytes.
    Thomsen AR; Jensen BL
    Scand J Immunol; 1980; 12(2):109-18. PubMed ID: 6160612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-mediated cytotoxicity against tumor cells specificity and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Waterfield EM; Anaclerio A; Möller G
    Transplant Rev; 1976; 29():277-310. PubMed ID: 58460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologically specific cytolytic activity induced in long-term mixed leukocyte culture cells by concanavalin A.
    Tartof D; Fitch FW
    J Immunol; 1977 Jan; 118(1):35-42. PubMed ID: 137263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cytotoxic function in T lymphocytes.
    Heininger D; Touton M; Chakravarty AK; Clark WR
    J Immunol; 1976 Dec; 117(6):2175-80. PubMed ID: 136475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency.
    Bevan MJ; Langman RE; Cohn M
    Eur J Immunol; 1976 Mar; 6(3):150-6. PubMed ID: 62665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
    Holladay FP; Lopez G; De M; Morantz RA; Wood GW
    Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper T cells are required for the polyclonal stimulation of cytotoxic T cells by concanavalin A.
    Pilarski LM; Bretscher PA; Baum LL
    J Exp Med; 1977 May; 145(5):1237-49. PubMed ID: 300781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concanavalin A potentiates syngeneic response in murine lymphocytes.
    Ozato K; Ebert JD
    J Exp Med; 1976 Jan; 143(1):1-14. PubMed ID: 127828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic action of spleen lymphocytes to simian virus 40-induced tumor cells.
    Egusa K
    Acta Med Okayama; 1973 Aug; 27(3):107-23. PubMed ID: 4357059
    [No Abstract]   [Full Text] [Related]  

  • 15. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming.
    Bevan MJ
    J Immunol; 1976 Dec; 117(6):2233-8. PubMed ID: 825578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concanavalin A-mediated in vitro activation of lymphocytes primed against syngeneic SV40-induced tumor-associated antigens in mice into secondary effector cells capable of specifically preventing tumor growth.
    Glaser M
    Cell Immunol; 1979 Aug; 46(1):201-7. PubMed ID: 226270
    [No Abstract]   [Full Text] [Related]  

  • 17. Lectin-driven maturation of cytotoxic effector cells: the nature of effector memory.
    Chakravarty AK; Clark WR
    J Exp Med; 1977 Jul; 146(1):230-40. PubMed ID: 301545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effect of concanavalin-A. II. In vivo suppression of cytotoxic lymphocytes generation in alloimmunized mice.
    Wasik M; Skopińska E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):331-3. PubMed ID: 749783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capacity of different cell types to prime in vivo for secondary in vitro cytotoxic T-cell responses against non-major-histocompatibility antigens.
    Buszello H; Helm K; Dröge W
    Cell Immunol; 1984 Dec; 89(2):331-41. PubMed ID: 6334562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.